Company profile: ACell
1.1 - Company Overview
Company description
- Provider of extracellular matrix devices and acellular, resorbable MatriStem/UBM matrices for tissue repair and remodeling in surgical and wound care, including Cytal Wound Matrix, Cytal Burn Matrix, MicroMatrix UBM Particulate, and Gentrix Surgical Matrix.
Products and services
- Gentrix® Surgical Matrix: A surgical-grade product that employs UBM technology to support tissue repair and remodeling during surgical procedures
- Cytal® Wound Matrix: A clinical-grade product engineered to aid repair and remodeling of damaged tissues, utilizing UBM technology in wound matrix applications
- MicroMatrix® UBM Particulate: A particulate-scale UBM material used for various applications in tissue repair and remodeling
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ACell
BioStem Technologies
HQ: United States
Website
- Description: Provider of placental-derived tissue allografts and regenerative medicine technologies, including VENDAJE and VENDAJE AC for protective covering of soft tissue wounds, VENDAJE OPTIC for ocular surface repair, and AmnioWrap2 to support natural healing. Offers BioREtain, a perinatal tissue processing method preserving growth factors and tissue structure, and Local MicroEnvironment Activation to promote tissue repair.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioStem Technologies company profile →
PolarityTE
HQ: United States
Website
- Description: Provider of SkinTE, an investigational product for complex chronic and acute wound treatment that uses a patient's own tissue to regenerate functional skin, and a clinical development program advancing SkinTE through clinical trials to obtain regulatory approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PolarityTE company profile →
Cutiss
HQ: Switzerland
Website
- Description: Provider of regenerative medicine and skin tissue engineering solutions, including denovoSkin, a personalized bio-engineered skin graft for permanent treatment of skin defects and injuries; Viticell, a CE-marked cell therapy for vitiligo and dyspigmented burn scars; automated manufacturing of tissue therapies, clinical development programs, and named-patient basis treatment options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cutiss company profile →
Artelon
HQ: United States
Website
- Description: Provider of bio-textile solutions for kinematic reinforcement of tendon and ligament reconstruction, developing synthetic materials for tissue reconstruction and restoring stability and motion. Products include FLEXBAND biomaterial and systems (Twist, Solo, Multi, FIX), FLEXBAND Plus, FLEXPATCH, Dynamic Matrix Technology used in over 60,000 implantations, and educational programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Artelon company profile →
Bonesupport
HQ: Sweden
Website
- Description: Provider of injectable osteoconductive biomaterials for treating fragility fractures from osteoporosis and bone voids or gaps caused by trauma, disease, or surgical procedures. Offers CERAMENT, a range of injectable osteoconductive and drug-eluting bioceramic products for bone voids and fractures that remodel to host bone within six to twelve months.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bonesupport company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ACell
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ACell
2.2 - Growth funds investing in similar companies to ACell
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ACell
4.2 - Public trading comparable groups for ACell
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →